NanJing Pharmaceutical Company Limited (SHA:600713)

China flag China · Delayed Price · Currency is CNY
5.22
+0.03 (0.58%)
Dec 5, 2025, 3:00 PM CST
1.16%
Market Cap6.79B
Revenue (ttm)53.89B
Net Income (ttm)530.72M
Shares Out1.31B
EPS (ttm)0.38
PE Ratio13.74
Forward PEn/a
Dividend0.17 (3.26%)
Ex-Dividend DateJun 30, 2025
Volume13,163,900
Average Volume14,977,962
Open5.17
Previous Close5.19
Day's Range5.13 - 5.23
52-Week Range4.55 - 5.64
Beta0.33
RSI53.37
Earnings DateMar 31, 2026

About SHA:600713

NanJing Pharmaceutical Company Limited engages in the drug distribution businesses in China. It also involved in the wholesale and retail of medical device distribution; pharmaceutical logistics; and internet drug retail business. NanJing Pharmaceutical Company Limited was founded in 1951 and is based in Nanjing, China. [Read more]

Sector Healthcare
Founded 1951
Employees 4,830
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600713
Full Company Profile

Financial Performance

In 2024, SHA:600713's revenue was 53.70 billion, an increase of 0.20% compared to the previous year's 53.59 billion. Earnings were 570.63 million, a decrease of -1.25%.

Financial Statements

News

There is no news available yet.